A proportion of ETP-ALL cases, characterized by a CD3+, CD1a-, CD8-, and CD5-/weak phenotype, along with expression of myeloid-associated markers, may have immunophenotypic features that overlap with those of T/myeloid MPAL. This evidence concerns the gene CD5 and mixed phenotype acute leukemia.